Portland Press Limited has announced that their first consortium proposal to Japan has been approved by the Japan Medical Library Association (JMLA) and Japan Pharmaceutical Library Association (JPLA), by assistance of USACO Corporation, their exclusive agent in Japan.
This consortium proposal allows JMLA and JPLA members to purchase new or additional subscriptions and the PPL Legacy Package at the special discounted prices. This proposal is opt-in model, which individual members can decide to join or not.
Portland Press Limited, the wholly-owned trading subsidiary of the Biochemical Society, is an innovative publisher of journals, books and electronic resources. It prides itself on leading the way in content innovation, open access publishing and the delivery of high quality molecular and cellular biosciences research. PPL aims to serve both the scientific community and the aims of the Society in its pursuit of excellence and scientific progression.
